These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7761768)

  • 21. [Non-steroidal anti-inflammatory agents and cyclooxygenases].
    Vergne P; Bertin P; Bonnet C; Rigaud M; Treves R
    Therapie; 1996; 51(6):639-46. PubMed ID: 9164000
    [No Abstract]   [Full Text] [Related]  

  • 22. [Non-steroidal anti-inflammatory agents and their actions on mitochondrial function].
    Reyes PA; Chávez E; Gil HA; Bravo C
    Gac Med Mex; 1986; 122(5-6):157-65. PubMed ID: 3596127
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro effect of different non-steroidal anti-inflammatory drugs on human polymorphonuclear leukocyte activity measured by luminol-dependent chemiluminescence of the whole blood.
    Abdullah AS; Jawad AM; Al-Hashimi AH
    Saudi Med J; 2001 Apr; 22(4):360-5. PubMed ID: 11331497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do non-steroidal anti-inflammatory drugs interfere with low dose aspirin therapy?
    Mendis L
    Ceylon Med J; 1993 Sep; 38(3):145-6. PubMed ID: 7828240
    [No Abstract]   [Full Text] [Related]  

  • 25. Re-classification of NSAIDs.
    Griswold DE; Ruffolo RR; Poste G; Torphy TJ
    Trends Pharmacol Sci; 1997 Sep; 18(9):311-2. PubMed ID: 9345847
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anti-inflammatory agents and analgesics].
    Tsutsumi S; Takai H
    Nihon Shika Ishikai Zasshi; 1976; 28(2):1256-75. PubMed ID: 1086878
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
    Hirohata M; Ono K; Morinaga A; Yamada M
    Neuropharmacology; 2008 Mar; 54(3):620-7. PubMed ID: 18164319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-steroidal anti-inflammatory agents (NSAID's) with lesser side effects by selective inhibition of cyclo-oxygenase-2].
    Bijlsma JW; Van de Putte LB
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1762-5. PubMed ID: 9856140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastroduodenal complications associated with non-steroidal anti-inflammatory drugs in Slovak Republic: results of one-year prospective study].
    Rybár I; Hlísta M; Masaryk P; Rovenský J; Hyrdel R; Kriska M
    Vnitr Lek; 2006; 52(7-8):673-6. PubMed ID: 16967607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of non-steroidal anti-inflammatory drugs on blood pressure.
    Spence JD
    J Hypertens; 2007 Jan; 25(1):248; author reply 248-9. PubMed ID: 17143199
    [No Abstract]   [Full Text] [Related]  

  • 35. Hydrogen sulfide-releasing anti-inflammatory drugs.
    Wallace JL
    Trends Pharmacol Sci; 2007 Oct; 28(10):501-5. PubMed ID: 17884186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.
    Murthy SK; Kauldher S; Targownik LE
    Aliment Pharmacol Ther; 2006 May; 23(9):1365-72. PubMed ID: 16629943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
    Cryer B; Miller P; Petruschke RA; Chen E; Geba GP; Papp AE
    Aliment Pharmacol Ther; 2005 Mar; 21(5):599-607. PubMed ID: 15740544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.